Skip to main content
Clinical Trials/NL-OMON55562
NL-OMON55562
Completed
N/A

A prospective, multi-centre study investigating the incidence and prognosis of relapses, pseudo-relapses and other causes of (sub)acute neurological symptoms in patients with relapsing-remitting multiple sclerosis. - RELAMS study

Sint Elisabeth Ziekenhuis0 sites125 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
Sint Elisabeth Ziekenhuis
Enrollment
125
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

Trial is onging in other countries

Registry
who.int
Start Date
TBD
End Date
May 16, 2023
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Sponsor
Sint Elisabeth Ziekenhuis

Eligibility Criteria

Inclusion Criteria

  • \* The subject must give written informed consent
  • \* The subject is between the age of \*18 and \*55 years
  • \* The subject suffers from RRMS or CIS
  • \* The subject has an EDSS of 5\.5 or less prior to baseline (e.g. ambulatory
  • without aid for about 100 meters)
  • \* The subject has experienced (sub)acute neurological symptoms within 14 days
  • before visit
  • \* The subject must be prepared to and considered able to follow the protocol
  • during the whole trial period and to attend the planned visits

Exclusion Criteria

  • \* The subject has received treatment with glucocorticoids within one month
  • prior to the inclusion in the study
  • \* The subject has experienced a relapse within one month prior to inclusion in
  • \* The subject has already been included in this study during a previous episode
  • of symptoms

Outcomes

Primary Outcomes

Not specified

Similar Trials